Author:
Sobol-Milejska Grazyna,Mizia-Malarz Agnieszka,Wos Halina
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Amirghofran Z, Daneshbod Y, Gholijani N, Esmaeilbeib M. The influence of Bcl-2 and myeloid antigen expression on response to therapy in childhood acute lymphoblastic leukemia. Arch Iran Med. 2011;14:170–4.
2. Suggs JL, Cruse JM, Lewis RE. Aberrant myeloid marker expression in precursor B-cell and T-cell leukemia. Exp Mol Pathol. 2007;83:471–3.
3. Tanyeli A, Erbey F, Bayram I, Kömür M. myeloid antigen positivity in Turkish children with acute lymphoblastic leukemia lacks influence on prognosis. Asian Pac J Cancer Prev. 2010;11:1823–6.
4. Abdelhaleem M. Frequent but nonrandom expression of myeloid markers on de novo childhood acute lymphoblastic leukemia. Exp Mol Pathol. 2007;83:138–41.
5. Tong H, Wang Q, Lu C, et al. Immunophenotypic, cytogenetic, and clinical features of 207 cases of childhood acute lymphoblastic leukemia in China. J Pediatr Hematol Oncol. 2011;33:437–41.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Is tumour-expressed aminopeptidase N (APN/CD13) structurally and functionally unique?;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2021-12
2. References;Flow Cytometry of Hematological Malignancies;2021-04-06